Artificial pancreas improves blood sugar levels in type 2 diabetes trial

Researchers from universities of Bern (in Switzerland), Manchester and Cambridge (in England) studied 136 adults with type 2 diabetes, all of whom took insulin and were receiving noncritical care.

They spilt them into two groups, where 66 received care as usual governed by their own local healthcare professionals, and 70 were on a closed-loop insulin delivery.

Average glucose levels were significantly better within the artificial pancreas group 8.6 mmol/l (154 mg/dl), and this compared with 10.4 mmol/l (188 mg/dl) in the control group.

Leave a Reply

Your email address will not be published. Required fields are marked *